UTRN and Duchenne muscular dystrophy: A previous report showed that bone marrow-derived mesenchymal stromal cells injected into the peritoneal cavity ameliorated the pathology of dystrophin/utrophin double-knockout mice, a mouse model of severe DMD [8].